Microenvironmental Influence on Pre-Clinical Activity of Polo-Like Kinase Inhibition in Multiple Myeloma: Implications for Clinical Translation

PLoS ONE - United States
doi 10.1371/journal.pone.0020226
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

A Perspective on Polo-Like Kinase-1 Inhibition for the Treatment of Rhabdomyosarcomas

Frontiers in Oncology
Cancer ResearchOncology
2019English

Polo-Like Kinase 4 Inhibition: A Strategy for Cancer Therapy?

Cancer Cell
Cancer ResearchOncologyCell Biology
2014English

Clinical Implications of Targeting XPO1-Mediated Nuclear Export in Multiple Myeloma

Clinical Lymphoma, Myeloma and Leukemia
Cancer ResearchOncologyHematology
2018English

Clinical Research Protocols for Multiple Myeloma

Cancer Control
MedicineOncologyHematology
1998English

Inhibition of Polo-Like Kinase 1 (Plk1) Enhances the Antineoplastic Activity of Metformin in Prostate Cancer

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2014English

Clinical Implications of Cytogenetic Heterogeneity in Multiple Myeloma Patients With TP53 Deletion

Modern Pathology
Forensic MedicinePathology
2017English

Downregulation of Human Polo-Like Kinase Activity by Antisense Oligonucleotides Induces Growth Inhibition in Cancer Cells

Oncogene
Cancer ResearchGeneticsMolecular Biology
2002English

Enabling and Disabling Polo-Like Kinase 1 Inhibition Through Chemical Genetics

ACS Chemical Biology
BiochemistryMedicineMolecular Medicine
2012English

Inhibition of Polo-Like Kinase 2 Ameliorates Pathogenesis in Alzheimer’s Disease Model Mice

PLoS ONE
Multidisciplinary
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy